Focus on Hormone Replacement ResearchNova Publishers, 2004 - Всего страниц: 172 Hormone replacement therapy is now simply called hormone replacement because of research discoveries identifying possible severe risks associated with this treatment which was very favourably viewed earlier. Now the lowest effective dose and the shortest duration of treatment acceptable is advised. This new book presents state-of-the-art research from around the world in HR and its relation to endometrial cancer, cardiovascular disease, Alzheimer's disease, schizophrenia, mood and anxiety disorders, Parkinson's disease, Huntington's disease and bone mass. |
Содержание
1 | |
Postmenopausal Hormone Replacement Therapy and Cardiovascular Disease | 27 |
Hormone Replacement Therapy and Cardiovascular Disease The Remains of the Evidence | 43 |
Thromboembolism and Coronary Heart Disease In Which Aspects are Women Different? | 59 |
Effects of Estradiol17ß Implications for Alzheimers Disease and Schizophrenia | 85 |
A Potential Therapeutic Role for Estrogens in Psychiatric and Neurological Diseases | 99 |
Secreting Ovarian Tumors Effects of Surgery and Hormone Replacement Therapy on Bone Mass | 127 |
Practical Aspects of Testosterone Substitution | 137 |
Endometrial Cancer Risk Assessment Detection Management and Surveillance | 151 |
Index | 169 |
Часто встречающиеся слова и выражения
Alzheimer's disease androgen associated atherosclerosis BDNF beneficial effects bone mass bone mineral density Brain Res breast cancer calcium cardiovascular disease cardiovascular events cells Clin clinical trials cognitive compared coronary artery coronary heart disease CREB decrease disorders dopamine dose drugs effects of estrogen endometrial cancer endothelial function Engl estradiol estradiol-17ẞ estrogen plus progestin estrogen receptor estrogen replacement therapy factor V Leiden female follow-up gene Grady healthy postmenopausal women hormone replacement therapy hormone therapy hypogonadism increased risk JAMA LDL particles lipid lipoprotein male menopause metabolism modulate myocardial infarction neurons neuroprotective Neurosci Obstet Gynecol oral estrogen osteoporosis oxidative patients placebo Postmenopausal hormone premenopausal progesterone progestin protein Psychiatry raloxifene randomized controlled trial randomized trial recurrent reduced risk factors role schizophrenia secondary prevention steroid syndrome tardive dyskinesia testosterone testosterone levels testosterone undecanoate transdermal triglyceride vascular venous thromboembolism Women's Health Initiative
Популярные отрывки
Стр. 58 - Cummings SR, Eckert S, Krueger KA et al. The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial.
Стр. 19 - Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial.
Стр. 120 - Kuiper GG, Enmark, E., Pelto-Huikko, M., Nilsson, S., Gustafsson, JA, 1996. Cloning of a novel receptor expressed in rat prostate and ovary.
Стр. 123 - Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90: 8098- 1 02.
Стр. 123 - GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen.
Стр. 53 - Herrington DM, Reboussin DM, Brosnihan KB et al. Effects of estrogen replacement on the progression of coronary-artery atherosclerosis.
Стр. 25 - Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
Стр. 116 - Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, Carlquist M 1997 Molecular basis of agonism and antagonism in the oestrogen receptor.
Стр. 37 - Grodstein F, Stampfer MJ, Manson JE, et al. Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med.